|
|
Home > Healthcare > Biotechnology > Cell/Tissue Engineering
Stem Cell Markets
|
|
| A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential. The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. It examines the use of stem cells in developing new therapies for disease.
|
Similar Products
• Regenerative Medicines: Bone and Joint Applications
Published Oct 2009 by BCC Research
• Growth Factors (Blood And Tissue)
Published Oct 2008 by Global Industry Analysts
• Advances in Replacement Organs and Tissue Engineering (Technical Insights)
Published Sep 2008 by Frost & Sullivan
• Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Published Mar 2008 by Kalorama Information
• Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
Published Jul 2007 by Medtech Insight
• Stem Cell - Analysis and Market Forecasts, 2006-2016
Published Mar 2007 by RRY Publications
• Tissue Engineering & Stem Cell Technology Report 2007
Published Feb 2007 by Visiongain
• Hitting the Bull's-Eye with Your Eyes Closed: The Stem Cell Magic Bullet
Published Dec 2006 by IDC
• New Options for Treating Neurological Disease: Stem Cell Therapy
Published Dec 2006 by Decision Resources
|
|
|
|
0 items
